Advertisement
U.S. markets closed

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
9.47-0.14 (-1.46%)
At close: 04:00PM EST
9.50 +0.03 (+0.32%)
After hours: 05:41PM EST
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts3233
Avg. Estimate0.23-0.06-0.110.81
Low Estimate-0.15-0.07-0.480.5
High Estimate0.88-0.060.61.1
Year Ago EPS0.03-0.09-0.39-0.11
Revenue EstimateCurrent Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts5355
Avg. Estimate27.32M16.1M72.9M102.95M
Low Estimate14.9M14.5M60.6M76.7M
High Estimate68.08M18M113.71M132.43M
Year Ago Sales17.57M14.5M57.42M72.9M
Sales Growth (year/est)55.52%11.01%26.95%41.21%
Earnings History12/30/20233/30/20246/29/20249/29/2024
EPS Est.-0-0.12-0.07-0.1
EPS Actual0.03-0.09-0.13-0.06
Difference0.030.03-0.060.04
Surprise %970.87%21.58%-85.71%42.90%
EPS TrendCurrent Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate0.23-0.06-0.110.81
7 Days Ago0.25-0.05-0.120.96
30 Days Ago0.25-0.05-0.120.96
60 Days Ago0.25-0.05-0.120.96
90 Days Ago0.25-0.05-0.120.96
EPS RevisionsCurrent Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days3N/A32
Growth EstimatesTBPHIndustrySector(s)S&P 500
Current Qtr.693.10%N/AN/AN/A
Next Qtr.30.92%N/AN/AN/A
Current Year71.77%N/AN/AN/A
Next Year836.36%N/AN/AN/A